Free Corporate Rating

Free Corporate Rating

Discover how companies are aligning with the Paris Agreement’s goal of limiting global warming to 2°C. This tool provides you with up-to-date climate ratings, reflecting a company’s progress and commitment to sustainable practices. Whether you're an investor, policymaker, or eco-conscious consumer, our platform simplifies your search for transparent, data-driven insights on corporate climate performance.
Start exploring now and make informed decisions for a sustainable future !

VERTEX PHARMACEUTICALS INCORPORATED

Health Care

ISIN

US92532F1003

LEI

54930015RAQRRZ5ZGJ91

Description

Vertex Pharmaceuticals, Inc. is a biotechnology company that develops and commercializes innovative medicines to treat serious diseases. It focuses on developing treatments for cystic fibrosis, hepatitis C, and other diseases of the liver, kidney, and central nervous system.
En transition
• SB2A Temperature Range: 2°C ≤ SB2A < 3°C • Description: Transitioning companies are actively engaged in reducing their carbon footprint. The decrease in the carbon intensity at company level is the sign that these entities are making strides toward sustainability, even if a specific reduction target is yet to be formalized.

Rating peers in sector of Health Care (based on 265 companies)

9%
Leader
9%
Aligné
5%
En
transition
active
VERTEX PHARMACEUTICALS INCORPORATED
27%
En
transition
40%
Non
aligné
10%
Faibles

Get in touch!

Want to know more? Fill out the form or reach us directly via email at contact@icebergdatalab.com.

France
ICEBERG DATA LAB
39 Avenue Victor Hugo
75116 Paris
📞 +33 1 89 71 64 00
United Kingdom
ICEBERG DATA LAB
1 Fore Street Avenue
EC2Y 9DT London
Germany
ICEBERG DATA LAB
Platz der Einheit 2
60327 Frankfurt am Main, Frankfurt
United States
ICEBERG DATA LAB
100 Cummings Center
Beverly, MA 01915
📞 +1 (351) 235-2879